Effects of fludarabine and gemcitabine on human acute myeloid leukemia cell line HL 60: Direct comparison of cytotoxicity and cellular Ara-C uptake enhancement

Leukemia Research

Volumn 20, Issue 1, 1996, Pages 37-45

  Santini, Valeria ^a,b   D'Ippolito, Gianluca ^a   Bernabei, Pietro Antonio ^a   Zoccolante, Antonella ^a   Ermini, Angela ^a   Rossi Ferrini, Pierluigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Policlinico di Careggi   (Italy)

Author keywords

Acute leukemia; Apoptosis; Arabinosylcytosine; Cell cycle; Fludarabine; Gemcitabine

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; FLUDARABINE; GEMCITABINE; TRITIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLAST CELL; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG UPTAKE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0030022046     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00106-9     Document Type: Article

References (28)

1. Clarkson D. B., Dowling M. D., Gee T. S., Cunningham I. B. & Burchenal J. H. (1975) Treatment of acute leukemia in adult. Cancer 36, 775-795.
2. Petti M. C., Broccia G. & Carona F. (1990) Therapy of acute myelogenous leukemia in adults. Haematol. Blood Transf. 33, 240-253.
3. Yates J., Glidewell O. & Wiernik P. (1982) Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia; a CALGB study. Blood 60, 454-462.
4. Rees J. K. H. & Gray R. (1990) Remission induction and post remission therapy in acute myelogenous leukemia: British MRC Study. Hematol. Blood Transf. 33, 243-248.
5. Kufe D. W. & Spriggs D. R. (1985) Biochemical and cellular pharmacology of cytosine arabinoside. Semin. Oncol. 12(2) (Suppl. 3), 34-38.
6. Rustum Y. M. & Preisler H. D. (1979) Correlation between cell retention of 1-β-D-arabinofuranosylcytosine-5′-triphosphate and response to therapy. Cancer Res. 39, 42-49.
7. Kufe D. W., Spriggs D. R., Egan E. M. & Munroe D. (1984) Relationship among Ara-CTP pools, formation of (Ara-C) DNA and cytotoxicity of human leukemic cells. Blood 64(1), 54-58.
8. Liliemark J. O. & Plunkett W. (1986) Regulation of 1-D-β-arabinofuranosylcytosine-5′-triphosphate accumulation in human leukemia cells by deoxycytidine 5′-triphosphate. Cancer Res. 46, 1079-1083.
9. Kufe D. W., Major P. P., Munroe D., Egan M. & Herrick D. (1983) Relationship between incorporation of 9-β-D-arabinofuranosyladenine in L1210 DNA and cytotoxicity. Cancer Res. 43, 2000-2004.
10. Coleman C. N., Stoller R. G., Drake J. C. & Chabner B. A. (1975) Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes. Blood 46, 791-803.
11. Ross D. D., Thompson B. W., Joneckis C. C., Ackman S. A. & Schiffer C. (1986) Metabolism of Ara-C by blast cells from patients with ANLL. Blood 68, 76-87.
12. Jamieson G. P., Snook M. B. & Wiley J. (1990) Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells. Leukemia Res. 14(5), 475-479.
13. Preisler H. D., Epstein J., Raza A., Azarnia N., Brown G., Booker L., Goldberg J., Gottlieb A., Brennan J., Grumwald H., Rai K., Vogler R., Winton L., Miller K. & Larson R. (1984) Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease. Eur. J. Cancer Clin. Oncol. 20(8), 1061-1068.
14. Gandhi V. & Plunkett W. (1988) Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Cancer Res. 48, 329-334.
15. Gandhi V., Nowak B., Keating M. J. & Plunkett W. (1989) Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implication for combination therapy. Blood 74, 2070-2075.
16. Keating M. J., Kantarjan H., Talpaz M., Redman J., Koller C., Barlogie B., Velasquez W., Plunkett W., Freireich E. J. & McCredie K. B. (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 74, 19-25.
17. Gandhi V., Estey E., Keating M. J. & Plunkett W. (1993) Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J. Clin. Oncol. 11, 116-124.
18. Hertel L. W., Border G. B., Kroin J. S., Rinzel S. M., Poore G. A., Todd G. C. & Grindey G. B. (1990) Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine). Cancer Res. 50, 4417-4422.
19. Gandhi V. & Plunkett W. (1990) Modulatory activity of 2′,2′-difluoro-2′deoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res. 50, 3675-3680.
20. Fossella F. V. (1994) Dose scheduling and dosage of gemcitabine. Symposium on gemcitabine at the 7th World Conference on Lung Cancer. Colorado Springs, 26 June-1 July 1994, pp. 18-21 (abstr.).
21. Gatzemeier U., Sheperd F., Le Chevalier T. et al. (1994) A multicenter phase II trial with gemcitabine in non-small cell lung cancer (NSCLC). Lung Cancer II (Suppl. 1), 461 (abstr.).
22. Bouffard D. Y., Momparler L. F. & Momparler R. L. (1990) Comparison of antineoplastic activity of cytosine arabinoside and 2-2′-difluorodeoxicytidine on human myeloid, T-cell and B-cell leukemic cells. Eur. J. Pharmacol. 183, 239-240.
23. Heinamann V., Hertel L. V., Grindey G. B. & Plunkett W. (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′-2′-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res. 48, 4024-4031.
24. Pallavicini M. G. (1996) Cytosine arabinoside: molecular, pharmacokinetics and cytokinetic considerations. In Cell Cycle Effect of Drugs (Dethlefsen L. A., Ed.), pp. 136-162. Pergamon Press, New York.
25. Zittoun R., Marie J. P., Delamian S., Suberville A. M. & Thevenin D. (1987) Prognostic value of in vitro uptake and retention of cytosine arabinoside in acute myelogenous leukemia. Semin. Oncol. 14(1) (Suppl. 1).
26. Rayappa C. & McCulloch E. A. (1993) A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside. Leukemia 7, 992-999.
27. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassotas P. & Traganos F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808.
28. Robertson L. E., Chubb S., Meyn R. E., Story M., Ford R., Hittelman W. N. & Plunkett W. (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine. Blood 81, 143-150.